Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early and Accurate Detection of Prostate Cancer in General Practice Using Novel Molecular Biomarkers and Multiparametric MR Imaging.

NCT03431753 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT03431753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early and Accurate Detection of Prostate Cancer in General Practice Using Novel Molecular Biomarkers and Multiparametric MR Imaging.
Lead sponsor
Aarhus University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2018
Completion date
December 31, 2021
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, prostate cancer, prostate neoplasm